References
- Astrup T., Müllertz S., Rud Hansen J. The value of Owrens method of estimating prothrombin. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 209
- Bjerkelund Chr. J. The method of administering dicoumarol. Lancet 1953; 1: 260
- Bordet J., Delange L. La coagulation du sang et la genese de la thrombine. Ann. Inst. Pasteur 1912; 26: 737
- Fantl P., Nance M. H. The physiological activation of prothrombin. Med. J. Austral. 1948; 1: 128
- Frommeyer W. B., Corrigan H. Determination of prothrombin by the dilution method. J. Lab. & Clin. Med. 1949; 34: 1356
- Gollub S., Kaplan F. E., Meranze D. R., Tuft H. Critical adsorbtion levels and the electrophoretic analysis of “prothrombin-free” plasmas. Am. J. Clin. Pathol. 1949; 19: 1071
- Jaques L. B. The reducing properties of fibrinogen. Bioch. J. 1943; 37: 344
- Müllertz S. Scandinav. J. Clin. & Lab. Investigation 1953, in press
- Naninga L. Investigations on fibrinogen and thrombin, the second phase of blood coagulation. Amsterdam 1947
- Owren P. A. The coagulation of blood. Oslo 1947
- Owren P. A., Aas K. The control of dicoumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinav. J. Clin. & Lab. Investigation 1951; 3: 201
- Surgenor D. M., Noertker J. F. Preparation and properties of serum and plasma proteins. XXXIII. Specific interactions of prothrombin and other proteins with BaSO4. J. Am. Chem. Soc. 1952; 13: 3448
- Tanturi C. A., Banfi R. F. An improved method for the determination of plasma prothrombin. J. Lab. & Clin. Med. 1946; 31: 703
- Ware A. G., Guest M. M., Seegers W. H. A factor in plasma which accelerates the activation of prothrombin. J. Biol. Chem. 1947; 169: 231